Apollo, Fortis, Max Healthcare share prices rise 42-84% in a year: Should you Buy, Sell or Hold? Here's what experts say
Apollo Hospitals Enterprise Ltd, Fortis Healthcare , Max Healthcare Institute share prices have seen 42-84% gains during last year. The gains have been led by improved earnings outlook in the back of rising occupancy, increasing inpatient procedures, return of medical tourism and other such reasons have led to improvement in Average revenues pr operating bed (ARPOB). Apollo Hospitals Enterprise Ltd, Fortis Healthcare , Max Healthcare share prices also have benefit from rising capacities as expansions continue being carried out by them.
The outlook on growth momentum remains robust say analysts. CRISIL Ratings expect a double-digit revenue growth for Hospitals led by healthy occupancies and rising ARPOB. The revenue growth for private hospitals is expected to strong at 11-12% in fiscal 2025 after strong growth in fiscal 2024 which is estimated to have touched 14%.
Also Read- Neogen: Kotak Institutional recommends buying the stock, says firm has first-mover advantage in EV battery chemicals Its not only revenues but profits that will also get a boost. Better operating leverage will likely offset a cost ramp-up related to additional capacity, allowing operating profitability to remain stable at 16–17% in fiscal 2025, as per CRISIL. This will ensure that even when capital expenditures remain significant, cash generation will remain robust and dependency on external debt would be minimized.
Read more on livemint.com
